ROCKVILLE, MARYLAND , Sept 18, 2026 – The Acinetobacter pneumonia therapeutics market is projected to grow from USD 842.6 million in 2026 to USD 1,596.6 million by 2036, recording a compound annual growth rate (CAGR) of 6.6%. The market reached USD 790.4 million in 2025. Absolute opportunity over the forecast period totals USD 754.0 million.
The market covers...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek